Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The new generation of antifungal drugs.

× No keyword cloud information.

5 in total

1. Potential and problems with ketoconazole.

Authors: J R Graybill
Journal: Am J Med Date: 1983-01-24 Impact factor: 4.965

2. In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Authors: R S Gordee; D J Zeckner; L F Ellis; A L Thakkar; L C Howard
Journal: J Antibiot (Tokyo) Date: 1984-09 Impact factor: 2.649

Review 3. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

Authors: S P Clissold; R C Heel
Journal: Drugs Date: 1986-01 Impact factor: 9.546

4. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.

Authors: R M Tucker; P L Williams; E G Arathoon; B E Levine; A I Hartstein; L H Hanson; D A Stevens
Journal: Antimicrob Agents Chemother Date: 1988-03 Impact factor: 5.191

5. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

Authors: K Richardson; K W Brammer; M S Marriott; P F Troke
Journal: Antimicrob Agents Chemother Date: 1985-05 Impact factor: 5.191

5 in total

6 in total

1. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.

Authors: K V Clemons; M E Homola; D A Stevens
Journal: Antimicrob Agents Chemother Date: 1995-05 Impact factor: 5.191

Review 2. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.

Authors: Effie L Kuti; Joseph L Kuti
Journal: Expert Opin Drug Metab Toxicol Date: 2010-10 Impact factor: 4.481

The new generation of antifungal drugs.

1. Potential and problems with ketoconazole.

2. In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Review 3. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

4. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.

5. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.

1. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.

Review 2. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.

3. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.

4. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

5. Topical fluconazole for experimental candida keratitis in rabbits.

6. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning.